These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22297819)

  • 1. Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements?
    Bear AS; Morgan RA; Cornetta K; June CH; Binder-Scholl G; Dudley ME; Feldman SA; Rosenberg SA; Shurtleff SA; Rooney CM; Heslop HE; Dotti G
    Mol Ther; 2012 Feb; 20(2):246-9. PubMed ID: 22297819
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of replication competent retrovirus and lentivirus.
    Sastry L; Cornetta K
    Methods Mol Biol; 2009; 506():243-63. PubMed ID: 19110631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of Replication-Competent Lentivirus in the Clinic: Analysis of Infused T Cell Products.
    Cornetta K; Duffy L; Turtle CJ; Jensen M; Forman S; Binder-Scholl G; Fry T; Chew A; Maloney DG; June CH
    Mol Ther; 2018 Jan; 26(1):280-288. PubMed ID: 28970045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A facile method to increase titers of miRNA-encoding retroviruses by inhibition of the RNaseIII enzyme Drosha.
    Brandl A; Wittmann J; Jäck HM
    Eur J Immunol; 2011 Feb; 41(2):549-51. PubMed ID: 21268023
    [No Abstract]   [Full Text] [Related]  

  • 5. Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials.
    Cornetta K; Yao J; House K; Duffy L; Adusumilli PS; Beyer R; Booth C; Brenner M; Curran K; Grilley B; Heslop H; Hinrichs CS; Kaplan RN; Kiem HP; Kochenderfer J; Kohn DB; Mailankody S; Norberg SM; O'Cearbhaill RE; Pappas J; Park J; Ramos C; Ribas A; Rivière I; Rosenberg SA; Sauter C; Shah NN; Slovin SF; Thrasher A; Williams DA; Lin TY
    Mol Ther; 2023 Mar; 31(3):801-809. PubMed ID: 36518078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-retrovirus hybrid vectors achieve highly enhanced tumor transduction and antitumor efficacy in vivo.
    Kubo S; Haga K; Tamamoto A; Palmer DJ; Ng P; Okamura H; Kasahara N
    Mol Ther; 2011 Jan; 19(1):76-82. PubMed ID: 20808291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroviral Transduction of T Cells and T Cell Precursors.
    Simmons A; Alberola-Ila J
    Methods Mol Biol; 2016; 1323():99-108. PubMed ID: 26294401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety aspects of gene therapy.
    Cornetta K
    Br J Haematol; 1992 Apr; 80(4):421-6. PubMed ID: 1581226
    [No Abstract]   [Full Text] [Related]  

  • 9. Poxviral/retroviral chimeric vectors allow cytoplasmic production of transducing defective retroviral particles.
    Holzer GW; Falkner FG
    Methods Mol Med; 2003; 76():565-78. PubMed ID: 12526185
    [No Abstract]   [Full Text] [Related]  

  • 10. Gene transfer in avian embryos using replication-competent retroviruses.
    Logan C; Francis-West P
    Methods Mol Biol; 1999; 97():539-51. PubMed ID: 10443390
    [No Abstract]   [Full Text] [Related]  

  • 11. Retroviral and Lentiviral Safety Analysis of Gene-Modified T Cell Products and Infused HIV and Oncology Patients.
    Marcucci KT; Jadlowsky JK; Hwang WT; Suhoski-Davis M; Gonzalez VE; Kulikovskaya I; Gupta M; Lacey SF; Plesa G; Chew A; Melenhorst JJ; Levine BL; June CH
    Mol Ther; 2018 Jan; 26(1):269-279. PubMed ID: 29203150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene transfer in avian embryos using replication-competent retroviruses.
    Logan C; Francis-West P
    Methods Mol Biol; 2008; 461():363-76. PubMed ID: 19030811
    [No Abstract]   [Full Text] [Related]  

  • 13. Delivery of short hairpin RNA sequences by using a replication-competent avian retroviral vector.
    Bromberg-White JL; Webb CP; Patacsil VS; Miranti CK; Williams BO; Holmen SL
    J Virol; 2004 May; 78(9):4914-6. PubMed ID: 15078973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccinia viral/retroviral chimeric vectors.
    Falkner FG; Holzer GW
    Curr Gene Ther; 2004 Dec; 4(4):417-26. PubMed ID: 15578991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine gene-modified cell-based cancer vaccines.
    Reilly RT; Machiels JP; Emens LA; Jaffee EM
    Methods Mol Med; 2002; 69():233-57. PubMed ID: 11987781
    [No Abstract]   [Full Text] [Related]  

  • 16. Seek and You Will Not Find: Ending the Hunt for Replication-Competent Retroviruses during Human Gene Therapy.
    Heslop HE; Brenner MK
    Mol Ther; 2018 Jan; 26(1):1-2. PubMed ID: 29273500
    [No Abstract]   [Full Text] [Related]  

  • 17. Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols.
    Farson D; McGuinness R; Dull T; Limoli K; Lazar R; Jalali S; Reddy S; Pennathur-Das R; Broad D; Finer M
    J Gene Med; 1999; 1(3):195-209. PubMed ID: 10738568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental risk assessment of replication competent viral vectors applied in clinical trials: potential effects of inserted sequences.
    van den Akker E; van der Vlugt CJ; Bleijs DA; Bergmans HE
    Curr Gene Ther; 2013 Dec; 13(6):395-412. PubMed ID: 24397527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration site selection by retroviral vectors: molecular mechanism and clinical consequences.
    Daniel R; Smith JA
    Hum Gene Ther; 2008 Jun; 19(6):557-68. PubMed ID: 18533894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond oncolytic virotherapy: replication-competent retrovirus vectors for selective and stable transduction of tumors.
    Dalba C; Klatzmann D; Logg CR; Kasahara N
    Curr Gene Ther; 2005 Dec; 5(6):655-67. PubMed ID: 16457654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.